0001882991-26-000003.txt : 20260316 0001882991-26-000003.hdr.sgml : 20260316 20260316120350 ACCESSION NUMBER: 0001882991-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260316 DATE AS OF CHANGE: 20260316 EFFECTIVENESS DATE: 20260316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alphina Therapeutics, Inc. CENTRAL INDEX KEY: 0001882991 ORGANIZATION NAME: EIN: 872496192 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-576568 FILM NUMBER: 26755365 BUSINESS ADDRESS: STREET 1: 36 CHURCH LANE CITY: WESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: (203) 435-2255 MAIL ADDRESS: STREET 1: 36 CHURCH LANE CITY: WESTPORT STATE: CT ZIP: 06880 D 1 primary_doc.xml X0708 D LIVE 0001882991 Alphina Therapeutics, Inc. 55 Church Street New Haven CT CONNECTICUT 06510 (650) 438-8738 DELAWARE Athena Therapeutics, LLC None Corporation true Nicholas J Galli c/o Alphina, 55 Church Street New Haven CT CONNECTICUT 06510 Executive Officer Director Ranjit Bindra c/o Alphina, 55 Church Street New Haven CT CONNECTICUT 06510 Director Kevin Rakin c/o Alphina, 55 Church Street New Haven CT CONNECTICUT 06510 Director Colleen Cuffaro c/o Canaan, 285 Riverside Avenue Suite 250 Westport CT CONNECTICUT 06880 Director Barbara Fox c/o Alphina, 55 Church Street New Haven CT CONNECTICUT 06510 Executive Officer Director Matthew Cohen c/o Osage, 50 Monument Road Suite 201 Bala Cynwyd PA PENNSYLVANIA 19004 Director Biotechnology Decline to Disclose 06b false 2026-02-23 false true true Simple Agreements for Future Equity (SAFEs) false 0 10000000 153715 9846285 false 3 0 0 0 No amount other than ordinary course employment compensation is being paid to officers and directors. false Alphina Therapeutics, Inc. Nicholas J. Galli Nicholas J. Galli Chief Executive Officer 2026-03-16